Research Articles | Page 8 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium Aug 2020 Pediatric Blood & Cancer aplastic anemia, myelodysplastic syndromes (MDS), pediatric
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort Aug 2020 Pediatric Blood & Cancer aplastic anemia, pediatric
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Aug 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes Aug 2020 Cancer myelodysplastic syndromes (MDS)
Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes Aug 2020 Cancer myelodysplastic syndromes (MDS)
Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges Aug 2020 International Journal of Laboratory Hematology myelodysplastic syndromes (MDS)
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management Aug 2020 American Journal of Hematology myelodysplastic syndromes (MDS)
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Aug 2020 Nature Medicine myelodysplastic syndromes (MDS)
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial Aug 2020 Lancet Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab Aug 2020 American Journal of Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.